These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32977802)

  • 1. Impact of long-term glucose variability on coronary atherosclerosis progression in patients with type 2 diabetes: a 2.3 year follow-up study.
    Li S; Tang X; Luo Y; Wu B; Huang Z; Li Z; Peng L; Ling Y; Zhu J; Zhong J; Liu J; Chen Y
    Cardiovasc Diabetol; 2020 Sep; 19(1):146. PubMed ID: 32977802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visit-to-visit fasting plasma glucose variability is an important risk factor for long-term changes in left cardiac structure and function in patients with type 2 diabetes.
    Tang X; Zhong J; Zhang H; Luo Y; Liu X; Peng L; Zhang Y; Qian X; Jiang B; Liu J; Li S; Chen Y
    Cardiovasc Diabetol; 2019 Apr; 18(1):50. PubMed ID: 30992008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus.
    Wei F; Sun X; Zhao Y; Zhang H; Diao Y; Liu Z
    BMC Nephrol; 2016 Jul; 17(1):67. PubMed ID: 27386849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Fasting Plasma Glucose Targets on Glycemic Variability in Chinese Participants With Type 2 Diabetes: A Post Hoc Analysis of the FPG GOAL Trial (BEYOND III).
    Li L; Yang T; Xue Y; Ruan P; Du J; Li Y; Zhang X; Cui N; Yang W
    Adv Ther; 2022 Jan; 39(1):421-429. PubMed ID: 34757600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study.
    Scott ES; Januszewski AS; O'Connell R; Fulcher G; Scott R; Kesaniemi A; Wu L; Colagiuri S; Keech A; Jenkins AJ
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32766757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visit-to-visit HbA
    Yang CD; Shen Y; Lu L; Yang ZK; Hu J; Zhang RY; Shen WF; Ding FH; Wang XQ
    Cardiovasc Diabetol; 2020 Sep; 19(1):133. PubMed ID: 32887588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visit-to-Visit Variations in Fasting Plasma Glucose and HbA
    Li TC; Yang CP; Tseng ST; Li CI; Liu CS; Lin WY; Hwang KL; Yang SY; Chiang JH; Lin CC
    Diabetes Care; 2017 Sep; 40(9):1210-1217. PubMed ID: 28705834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes.
    Matsutani D; Sakamoto M; Minato S; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
    Cardiovasc Diabetol; 2018 Jul; 17(1):100. PubMed ID: 29991356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How well do glucose variability measures predict patient glycaemic outcomes during treatment intensification in type 2 diabetes?
    Inzucchi SE; Umpierrez G; DiGenio A; Zhou R; Kovatchev B
    Diabetes Res Clin Pract; 2015 Apr; 108(1):179-86. PubMed ID: 25661664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.
    Chiu HT; Li TC; Li CI; Liu CS; Lin WY; Lin CC
    PLoS One; 2017; 12(5):e0177184. PubMed ID: 28489885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic control is independently associated with rapid progression of coronary atherosclerosis in the absence of a baseline coronary plaque burden: a retrospective case-control study from the PARADIGM registry.
    Won KB; Lee BK; Lin FY; Hadamitzky M; Kim YJ; Sung JM; Conte E; Andreini D; Pontone G; Budoff MJ; Gottlieb I; Chun EJ; Cademartiri F; Maffei E; Marques H; de Araújo Gonçalves P; Leipsic JA; Lee SE; Shin S; Choi JH; Virmani R; Samady H; Chinnaiyan K; Berman DS; Narula J; Shaw LJ; Bax JJ; Min JK; Chang HJ
    Cardiovasc Diabetol; 2022 Nov; 21(1):239. PubMed ID: 36371222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose.
    Lin CC; Chen CC; Chen FN; Li CI; Liu CS; Lin WY; Yang SY; Lee CC; Li TC
    Am J Med; 2013 Nov; 126(11):1017.e1-10. PubMed ID: 23993260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of carotid atherosclerosis markers with all-cause and cardiovascular disease-specific mortality in persons with type 2 diabetes: a causal mediation analysis with glucose variation.
    Lin CC; Li CI; Liu CS; Lin CH; Yang SY; Li TC
    Acta Diabetol; 2024 May; 61(5):657-669. PubMed ID: 38393346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial glucose regulation: new data and new implications.
    Leiter LA; Ceriello A; Davidson JA; Hanefeld M; Monnier L; Owens DR; Tajima N; Tuomilehto J;
    Clin Ther; 2005; 27 Suppl B():S42-56. PubMed ID: 16519037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glucose variability on the mortality of adults aged 75 years and over during the first year of the COVID-19 pandemic.
    Salinero-Fort MA; San Andrés-Rebollo FJ; Cárdenas-Valladolid J; Mostaza J; Lahoz C; Rodriguez-Artalejo F; Gómez-Campelo P; Vich-Pérez P; Jiménez-García R; de-Miguel-Yanes JM; Maroto-Rodriguez J; Taulero-Escalera B; Campo VI;
    BMC Geriatr; 2024 Jun; 24(1):533. PubMed ID: 38902647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention.
    Nusca A; Tuccinardi D; Proscia C; Melfi R; Manfrini S; Nicolucci A; Ceriello A; Pozzilli P; Ussia GP; Grigioni F; Di Sciascio G
    Cardiovasc Diabetol; 2019 Nov; 18(1):147. PubMed ID: 31706305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI.
    Yang CD; Shen Y; Ding FH; Yang ZK; Hu J; Shen WF; Zhang RY; Lu L; Wang XQ
    Cardiovasc Diabetol; 2020 Sep; 19(1):131. PubMed ID: 32878604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study.
    Mukai N; Ninomiya T; Hata J; Hirakawa Y; Ikeda F; Fukuhara M; Hotta T; Koga M; Nakamura U; Kang D; Kitazono T; Kiyohara Y
    Cardiovasc Diabetol; 2015 Jun; 14():84. PubMed ID: 26099223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes.
    Jun JE; Jin SM; Baek J; Oh S; Hur KY; Lee MS; Lee MK; Kim JH
    Cardiovasc Diabetol; 2015 Jun; 14():70. PubMed ID: 26041130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Glycosylated Hemoglobin Variability and the Severity of Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus.
    Liu X; Yang X; Wu N
    J Diabetes Res; 2024; 2024():9958586. PubMed ID: 39118831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.